Found: 5
Select item for more details and to access through your institution.
901. MEDI8897 Prevents Serious RSV Disease in Healthy Preterm Infants.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S27, doi. 10.1093/ofid/ofz359.060
- By:
- Publication type:
- Article
Comprehensive Summary of Safety Data on Nirsevimab in Infants and Children from All Pivotal Randomized Clinical Trials.
- Published in:
- Pathogens, 2024, v. 13, n. 6, p. 503, doi. 10.3390/pathogens13060503
- By:
- Publication type:
- Article
Infants Receiving a Single Dose of Nirsevimab to Prevent RSV Do Not Have Evidence of Enhanced Disease in Their Second RSV Season.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2024, v. 13, n. 2, p. 144, doi. 10.1093/jpids/piad113
- By:
- Publication type:
- Article
Safety of Re-dosing Nirsevimab Prior to RSV Season 2 in Children With Heart or Lung Disease.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2023, v. 12, n. 8, p. 477, doi. 10.1093/jpids/piad052
- By:
- Publication type:
- Article
An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults.
- Published in:
- 2017
- By:
- Publication type:
- journal article